Antimalarial Activities of New Pyrrolo[3,2-f]Quinazoline-1,3-Diamine Derivatives

作者: Jian Guan , Quan Zhang , Michael O'Neil , Nicanor Obaldia , Arba Ager

DOI: 10.1128/AAC.49.12.4928-4933.2005

关键词: Therapeutic indexPlasmodium bergheiPlasmodium yoeliiBiological activityQuinazolinePotencyPlasmodium falciparumStereochemistryPlasmodium vivaxBiologyPharmacology

摘要: WR227825 is an antimalarial pyrroloquinazolinediamine derivative with a high potency but low therapeutic index. A series of carbamate, carboxamide, succinimide, and alkylamine derivatives were prepared to search for compounds improved The new acetamides imide showed potent cell growth inhibition against four clones Plasmodium falciparum (D-6, RCS, W-2, TM91C235), 50% inhibitory concentration approximately 0.01 ng/ml, highly active berghei, 100% cure at doses from <0.1 mg/kg body weight 220 mg/kg. carbamates alkyl derivatives, however, weak activity efficacious in tests P. berghei by the Thompson test. best compounds, bis-ethylcarbamate (compound 2a) tetra-acetamide (3a) further demonstrated sporozoite yoelii mice vivax aotus monkeys. Against AMRU-1 strain vivax, which has dihydrofolate reductase mutations resistant antifolates, 3a cured monkeys 1 3 Compound 2a only one out two results indicated that not have retained/improved efficacy parent compound also less toxic animals used tests.

参考文章(34)
Walter C. Earle, Manuel Perez, Enumeration of parasites in the blood of malarial patients Journal of Laboratory and Clinical Medicine. ,vol. 17, pp. 1124- 1130 ,(1932) , 10.5555/URI:PII:S0022214332903229
Edward F. Elslager, Marland P. Hutt, Patricia Jacob, Judith Johnson, Barbara Temporelli, Leslie M. Werbel, Donald F. Worth, Leo Rane, Folate antagonists. 15. 2,3-Diamino-6-(2-naphthylsulfonyl)quinazoline and related 2,4-diamino-6-[(phenyl and naphthyl)sulfinyl and sulfonyl]quinazolines, a potent new class of antimetabolites with phenomenal antimalarial activity. Journal of Medicinal Chemistry. ,vol. 22, pp. 1247- 1257 ,(1979) , 10.1021/JM00196A019
B.M. Greenwood, Population at risk Parasitology Today. ,vol. 6, pp. 188- ,(1990) , 10.1016/0169-4758(90)90351-4
Ayoade M.J. Oduola, Norman F. Weatherly, Jean H. Bowdre, Robert E. Desjardins, Plasmodium falciparum: Cloning by single-erythrocyte micromanipulation and heterogeneity in vitro Experimental Parasitology. ,vol. 66, pp. 86- 95 ,(1988) , 10.1016/0014-4894(88)90053-7
F Nosten, F ter Kuile, T Chongsuphajaisiddhi, N.J White, F ter Kuile, C Luxemburger, H.K Webster, M Edstein, L Phaipun, Kyaw Lay Thew, N.J White, Mefloquine-resistant falciparum malaria on the Thai-Burmese border. The Lancet. ,vol. 337, pp. 1140- 1143 ,(1991) , 10.1016/0140-6736(91)92798-7
A.M.J. Oduola, L.A. Salako, W.K. Milhous, O. Walker, R.E. Desjardins, REDUCED IN-VITRO SUSCEPTIBILITY TO MEFLOQUINE IN WEST AFRICAN ISOLATES OF PLASMODIUM FALCIPARUM The Lancet. ,vol. 330, pp. 1304- 1305 ,(1987) , 10.1016/S0140-6736(87)91195-0
Alan E. Greenberg, Mortality from Plasmodium falciparum Malaria in Travelers from the United States, 1959 to 1987 Annals of Internal Medicine. ,vol. 113, pp. 326- 327 ,(1990) , 10.7326/0003-4819-113-4-326
Patricia Schlagenhauf, Mefloquine for malaria chemoprophylaxis 1992-1998: a review. Journal of Travel Medicine. ,vol. 6, pp. 122- 133 ,(1999) , 10.1111/J.1708-8305.1999.TB00843.X
Jeffrey D. Chulay, J.David Haynes, Carter L. Diggs, Plasmodium falciparum: Assessment of in Vitro Growth by (3H)Hypoxanthine Incorporation Experimental Parasitology. ,vol. 55, pp. 138- 146 ,(1983) , 10.1016/0014-4894(83)90007-3